Mental health Psilocybin Therapy Reaches Final Stage: FDA Review Could Deliver Breakthrough in 2026 March 07, 2026
Mental health FDA Grants 'Breakthrough' Status to Rapid-Acting Psychedelic for Postpartum Depression February 24, 2026
